Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Baptist Health South Florida
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Plus Therapeutics
University of California, San Francisco
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
BPGbio
Wake Forest University Health Sciences
National Institutes of Health Clinical Center (CC)
Quadriga Biosciences, Inc.
Guangdong 999 Brain Hospital
Celgene
National Institutes of Health Clinical Center (CC)
University of California, San Diego
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
City of Hope Medical Center
AbbVie
Stanford University
National Institutes of Health Clinical Center (CC)
OHSU Knight Cancer Institute
Thomas Jefferson University
M.D. Anderson Cancer Center
Emory University
University of Iowa
National Cancer Institute (NCI)
Duke University
City of Hope Medical Center
University of California, San Francisco
The University of Texas Health Science Center at San Antonio
Tufts Medical Center
Vanderbilt-Ingram Cancer Center
Case Comprehensive Cancer Center
Pediatric Brain Tumor Consortium
Pharmacyclics LLC.
Myrexis Inc.
Copharos